ClinicalTrials.gg
CompletedNCT06593249Updated Dec 13, 2024

Management of Tick-borne Encephalitis

An observational study in Infectious Encephalitis, sponsored by University Medical Centre Ljubljana. Completed at 1 site in Slovenia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-13.

Sponsored by University Medical Centre Ljubljana · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
318
Ages
18 Years and older
Sex
All
01

Study summary

In this retrospective cohort study of patients with tick-borne encephalitis (TBE), potential differences in the clinical presentation at admission and diagnostic and therapeutic management of patients with TBE initially referred to infectious diseases or neurology departments were assessed. Associations between severity of acute illness and clinical outcome were also explored.

02

Conditions studied

  • Infectious Encephalitis

Keywords

  • tick-borne encephalitis
  • outcome
  • neuroimaging
  • lumbar puncture
  • clinical management
03

In context

Encephalitis, Tick-Borne

51 studies on the registry are indexed under Encephalitis, Tick-Borne; 9 are open to participants now.

This study's enrollment of 318 is below the median of 500 across 11 observational studies indexed under Encephalitis, Tick-Borne.

Browse Encephalitis, Tick-Borne studies →

Lead sponsor

University Medical Centre Ljubljana is the lead sponsor of 296 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with tick-borne encepalitis referred to Infectious diseases or Neurology departments of the University Medical Centre Ljubljana, Slovenia during the COVID-19 pandemic (from March 2020 to September 2022).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • microbiologically confirmed tick-borne meningoencephalitis

Exclusion criteria

Exclusion Criteria:

  • Exchanged between ID and neurology within the first 48 hours due to organizational constraints
  • Transferred from another hospital
  • Lumbar puncture not performed
  • Not fulfilling study criteria
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
318 participants (actual)
Patient registry
No

Groups and cohorts

  • TBE in Infectious Diseases Department

    patients with TBE referred to ID

    Other: No Intervention: Observational Cohort

  • TBE in Neurology Department

    Patients with TBE in Neurology Department

    Other: No Intervention: Observational Cohort

Interventions

  • OtherNo Intervention: Observational Cohort

    no intervention, observational study

06

What researchers measure

Primary outcomes

  1. head imaging

    Number (%) of patients with head imaging performed before proceeding to lumbar puncture.

    Time frame: at admission

07

Study locations

1 site
  • University Medical Centre Ljubljana, Ljublajana, Slovenia
    Ljubljana, Slovenia
08

References and documents

Individual participant data

Plan to share: Undecided — On reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2022 to primary completion in Sep 2023, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2024
First posted
Sep 19, 2024
StartActual
Sep 30, 2022
Primary completionActual
Sep 30, 2023
CompletionActual
Jun 30, 2024
Last update
Dec 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06593249
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Sep 30, 2022
Primary completion
Sep 30, 2023
Completion
Jun 30, 2024
Last update
Dec 13, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion